tradingkey.logo

iSpecimen Inc

ISPC
0.651USD
-0.099-13.17%
Fechamento 11/04, 16:00ETCotações atrasadas em 15 min
1.63MValor de mercado
PerdaP/L TTM

Mais detalhes de iSpecimen Inc Empresa

iSpecimen Inc. is a technology-driven company. The Company's iSpecimen Marketplace platform is designed to transform the biospecimen procurement process to accelerate medical discovery. The Company's technology consolidates the biospecimen buying experience in a single, online marketplace that brings together healthcare providers who have biospecimens and researchers across industry, academia, and government institutions who need them. Its iSpecimen Marketplace platform has compiled de-identified healthcare data provided by its healthcare supply partners. The platform is built upon a robust healthcare data set comprised of information about available specimens and research subjects. The Company’s platform helps with administrative and reporting functions for researchers, suppliers, and its internal personnel, including user and compliance management. The iSpecimen Marketplace technology comprises four functional areas: search, workflow, data, administrative, compliance and reporting.

Informações de iSpecimen Inc

Código da empresaISPC
Nome da EmpresaiSpecimen Inc
Data de listagemJun 17, 2021
CEOMr. Robert Bradley Lim
Número de funcionários24
Tipo de títulosOrdinary Share
Fim do ano fiscalJun 17
Endereço8 Cabot Road
CidadeWOBURN
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal08101
Telefone17813016700
Sitehttps://www.ispecimen.com/
Código da empresaISPC
Data de listagemJun 17, 2021
CEOMr. Robert Bradley Lim

Executivos da empresa iSpecimen Inc

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Mr. Robert Bradley Lim
Mr. Robert Bradley Lim
Chief Executive Officer, Treasurer, Secretary, Director
Chief Executive Officer, Treasurer, Secretary, Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President
President
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Avtar Dhaliwal
Mr. Avtar Dhaliwal
Independent Director
Independent Director
--
--
Mr. Robert Bradley Lim
Mr. Robert Bradley Lim
Chief Executive Officer, Treasurer, Secretary, Director
Chief Executive Officer, Treasurer, Secretary, Director
--
--
Ms. Siyun Yang
Ms. Siyun Yang
Independent Director
Independent Director
--
--
Ms. Katharyn (Katie) Field
Ms. Katharyn (Katie) Field
President
President
--
--
Mr. Anthony Lau
Mr. Anthony Lau
Independent Director
Independent Director
--
--
Ms. Yuying Liang, CPA
Ms. Yuying Liang, CPA
Chief Financial Officer
Chief Financial Officer
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por EmpresaUSD
Nome
Receita
Proporção
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%
Sem dados
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Specimens – contracts with customers
671.69K
94.19%
Shipping and other
41.44K
5.81%

Distribuição de ações

Atualizado em: qui, 2 de out
Atualizado em: qui, 2 de out
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
OBF Investments LLC
0.76%
Wolf (James G)
0.46%
Citadel Advisors LLC
0.35%
Geode Capital Management, L.L.C.
0.27%
UBS Financial Services, Inc.
0.25%
Outro
97.91%
Investidores
Investidores
Proporção
OBF Investments LLC
0.76%
Wolf (James G)
0.46%
Citadel Advisors LLC
0.35%
Geode Capital Management, L.L.C.
0.27%
UBS Financial Services, Inc.
0.25%
Outro
97.91%
Tipos de investidores
Investidores
Proporção
Corporation
0.76%
Hedge Fund
0.46%
Individual Investor
0.46%
Investment Advisor
0.33%
Investment Advisor/Hedge Fund
0.27%
Venture Capital
0.18%
Outro
97.54%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
26
68.69K
1.24%
-39.30K
2025Q2
31
133.51K
3.29%
-45.19K
2025Q1
37
201.48K
8.20%
-43.25K
2024Q4
37
175.36K
18.22%
-42.87K
2024Q3
38
178.54K
25.34%
-4.65K
2024Q2
37
155.60K
21.84%
-23.10K
2024Q1
38
168.39K
35.92%
-17.71K
2023Q4
42
174.70K
38.71%
-30.54K
2023Q3
48
208.00K
46.18%
-25.86K
2023Q2
48
208.72K
46.34%
-34.91K
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
OBF Investments LLC
42.10K
0.76%
+1.00
+0.00%
Dec 31, 2024
Wolf (James G)
25.25K
0.46%
-14.29K
-36.14%
Jun 03, 2024
Citadel Advisors LLC
19.46K
0.35%
+19.46K
--
Jun 30, 2025
Geode Capital Management, L.L.C.
14.81K
0.27%
+4.08K
+37.96%
Jun 30, 2025
UBS Financial Services, Inc.
14.03K
0.25%
-7.68K
-35.38%
Jun 30, 2025
XTX Markets LLC
10.08K
0.18%
+10.08K
--
Jun 30, 2025
Tower Research Capital LLC
6.19K
0.11%
+3.21K
+107.51%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
2.83K
0.05%
--
--
Jun 30, 2025
The Vanguard Group, Inc.
1.24K
0.02%
--
--
Aug 31, 2025
Brooks (John L III)
32.00
0%
--
--
Aug 18, 2025
Ver Mais

ETFs Relacionados

Nome
Proporção
Sem dados

Dividendo

Um total de 0.00 USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados

Desdobramento de ações

Data
Tipo
Proporção
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Data
Tipo
Proporção
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
Sep 11, 2024
Merger
20→1
KeyAI